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Abstract 
The external prognostic accuracy of Bipolar At Risk (BAR) criteria is undetermined and no 
psychometric tools are available to measure them. We present here three studies that overcome these 
limitations. Study 1 and 2 investigated the prognostic accuracy (Harrell’s C) of the original BAR and 
revised Bipolar At Risk States (BARS) criteria respectively for the prediction of bipolar disorders, 
using a retrospective cohort of individuals at Clinical High Risk for Psychosis (CHR-P). Study 3 
validated externally the prognostic accuracy of a newly developed Semistructured Interview of At 
Risk Bipolar States (SIBARS) in an independent prospective CHR-P cohort. In study 1 (n=205), those 
meeting BAR criteria had an increased risk of developing bipolar disorders (HR=5.30) relative to 
those not meeting them, but the prognostic accuracy was poor (Harrell’s C=0.659). In study 2 (n=205), 
those meeting the refined BARS criteria had a higher risk of developing bipolar disorders than those 
not meeting them (HR=12.364), with an adequate prognostic accuracy (Harrell’s C=0.777). Study 3 
(n=71) confirmed that SIBARS criteria had an adequate prognostic accuracy (Harrell's C=0.742) and 
clinical utility. Overall, these findings suggest that the SIBARS could be used for the detection of 
individuals at risk of developing bipolar disorders in CHR-P services.  
 
1. INTRODUCTION  
Early interventions in adolescence or young adulthood (Paus et al., 2008) have opened unprecedented 
opportunities for ameliorating the outcomes of serious mental disorders (McGorry, 2015). However, 
intervening in youths at the time of the first presentation of established mental disorders is associated 
with limited benefits. For example, early interventions at the time of a first episode of psychosis have 
no benefits on reducing the risk of relapse (Fusar-Poli et al., 2017b) or on shortening the duration of 
untreated psychosis (Oliver et al., 2017). Therefore it seems crucial to implement preventative 
strategies in youths who are at risk of developing mental disorders (Fusar-Poli, 2017). The model 
which has received the largest empirical support has validated indicated preventative interventions in 
individuals at Clinical High Risk of developing Psychosis (CHR-P hereafter) (Fusar-Poli, 2017). 
These individuals are detected through established psychometric interviews such as the 
Comprehensive Assessment of At risk Mental States (CAARMS) which was the first instrument 
developed to specifically assess the CHR-P group (Yung et al., 2005), and CHR-P services have been 
implemented worldwide (NICE, 2014; NHS England, 2016). Other semi-structured interviews have 
been developed and validated to assess CHR-P individuals (for a comparative analysis see.(Fusar-Poli 
et al., 2016c)).  Although these interviews have a good prognostic performance for the prediction of 
psychosis (Fusar-Poli et al., 2015a; Fusar-Poli and Schultze-Lutter, 2016) they can’t predict the 
development of any non-psychotic emergent mental disorder (Webb et al., 2015; Fusar-Poli et al., 
2017d). For example, CHR-P criteria are not associated with an increased risk of developing new 
bipolar disorders (HR=1.689, 95%CI 0.327 - 8.719 (Fusar-Poli et al., 2017d)). Therefore, new criteria 
and assessment instruments that can be used in CHR-P samples to detect youths at risk of developing 
bipolar disorders (Fusar-Poli et al., 2017d) are required. Bipolar disorder is a recurrent disorder with a 
lifetime prevalence between 0.1 and 4.4 percent (Merikangas et al., 2011). Its chronic course is 
associated with excess morbidity and mortality rates (Charlson et al., 2015), making bipolar disorder 
one of the main causes of disability among young and working-age people (Charlson et al., 2015). 
Early intervention strategies may help to modify the outcome of the illness, as early phases of bipolar 
disorders may be more responsive to treatment. Retrospective studies of adults with bipolar disorder 
indicate an onset of mood symptoms during childhood or adolescence, usually before the age of 21 
(Berk et al., 2014). The progressive nature (Kapczinski et al., 2017) of bipolar disorder supports the 
existence of milder phases of the condition prior to its classic presentation, which early detection 
efforts may be able to identify.	   A recent review on the results of longitudinal studies assessing 
potential predictors of development of bipolar disorder (Vieta et al., 2018) concluded that parental 
bipolar disorder, especially early-onset (e.g. <21 years old) parental bipolar disorder (Hafeman et al., 
2016), is the most important single risk factor for developing bipolar disorder. In addition, sub-
syndromal manic symptoms, which is the most consistent prodromal factor, and ongoing mood lability 
or irritability, anxiety, and depression, also increase the likelihood that a young person will develop 
bipolar disorder (Egeland et al., 2012). In line with these observations, preliminary Bipolar At Risk 
(BAR) criteria for assessing those who may be at risk of developing the disorder have been suggested 
(Bechdolf et al., 2010) (Table 1, left column). However, the use of these criteria in standard routine to 
assess youths seeking help at CHR-P services is currently limited by the lack of external validation in 
independent CHR-P samples, and of a proper psychometric instrument to collect and rate these 
features.  
 
The current study tackles these limitations by conducting three experiments, with the following aims: 
(i) to externally replicate the validity of the BAR criteria in CHR-P samples, to (ii) refine these criteria 
accounting for an expanded at risk phenotype (the Bipolar At Risk State, BARS), to (iii) validate the 
BARS criteria ascertained through a newly developed psychometric instrument that can be used to 
detect individuals at risk of developing bipolar disorders among those accessing CHR-P services. 
 
2 METHODS 
The current study consists of three experiments. In the first experiment (study 1) we have validated the 
BAR criteria, measured clinically, in a retrospective cohort of individuals under the care of a CHR-P 
clinic. In the second experiment (study 2) we have refined the BAR criteria by adding further 
symptoms which previous studies have identified as potential sub-threshold features of bipolar 
disorders (see 2.2 Data collection) and validated these new criteria (BARS) in the same cohort used in 
study 1. In the third experiment (study 3) we developed a new semi-structured instrument for the 
assessment of the BARS criteria from study 2 and validated it in another independent prospective 
cohort of individuals accessing CHR-P services.  
 
2.1 Sample  
Ethical permission for study 1 and 2 participants to be traced, contacted and interviewed was given by 
the South London and Maudsley NHS Mental Health Trust (SlaM) in Dec 2010. Study 1 and 2 were 
based on a retrospective cohort including all of the OASIS (“Outreach and Support in South-London”) 
patients considered to be at CHR-P after receiving a clinical assessment between 2001 and 2011. The 
details of the OASIS service, including clinical care offered and pathways to care, have been presented 
in separated manuscripts (Fusar-Poli et al., 2013; Fusar-Poli et al., 2015b; Fusar-Poli et al., 2016e). In 
brief, people are offered treatment at OASIS if, following assessment with the CAARMS (Yung et al., 
2005) CHR-P criteria are met. Therefore, all individuals included in study 1 and 2 met CHR-P criteria 
(CHR-P+ hereafter). Study 3 was approved in Sept 2017 as an audit study by the SLaM. It consisted 
of a new independent prospective cohort, which included patients undergoing a CHR-P assessment 
again at the OASIS between March 2013 and December 2015. Individuals eligible to enter in study 3 
could then receive a designation of being at risk for psychosis (CHR-P+), not at risk for psychosis 
(CHR-P-) or already affected with an established first episode of psychosis (FEP). 
Study 1, 2 and 3 were all conducted in the same group of patients accessing the OASIS. This is a 
clinical service located in Lambeth, Southwark, Croydon and Lewisham, South London, offering 
treatment to people at UHR between 14 and 35 years of age (Fusar-Poli et al., 2013). The catchment 
area has a large ethnic minority population and a high incidence of psychosis (Garety and Rigg, 2001). 
People are offered treatment at OASIS if, following assessment with the Comprehensive Assessment 
for the At-Risk Mental States (CAARMS (Yung et al., 2005)) by trained interviewers they met one or 
more of the following criteria, as objectively assessed by the clinicians of the team: a) attenuated (i.e. 
subthreshold) psychotic symptoms (APS) b) brief limited intermittent psychotic symptoms (a history 
of one or more episodes of frank psychotic symptoms that resolved spontaneously within 1 week in 
the past year; BLIPS) or c) a recent decline in function, together with either the presence of 
schizotypal personality disorder or a family history of psychosis in a first degree relative (Genetic Risk 
and Deterioration Syndrome, GRD). 
 
2.2 Data collection 
For study 1 and 2, clinical notes of OASIS patients written by psychiatrists responsible for the care of 
the patients after their first contact (including the baseline CAARMS report) with the patient were 
reviewed by an experienced clinician (IF) who was blinded to longitudinal outcomes to establish 
whether (1) BAR criteria (Bechdolf et al., 2010) and (2) the refined criteria (BARS; Table 1) were 
met. Definition of BAR and BARS criteria was based on an unstructured psychopathological 
assessment of the clinical records, in line with the previous attempts performed to identify clinically 
the BAR criteria (Bechdolf et al., 2010). Furthermore, a list of specific exclusion criteria was defined 
(Table 1). Refinement of BARS criteria with the inclusion of new subgroups was informed by 
evidence indicating that sub-threshold mixed episodes (Salvatore et al., 2007; Salvatore et al., 2014) 
and mood swings (Ozgurdal et al., 2009) may represent prodromal features of bipolar disorders. 
To ascertain the presence of mood symptoms, both sources (CAARMS and clinical notes) were 
consulted as, although the CAARMS scale does measure some mood symptoms, its main focus is on 
the assessment of sub-threshold psychotic symptoms. This procedure ensured that none of the 
available information on mood symptoms was missed. Information was regarded as insufficient and 
cases were excluded when neither the baseline CAARMS record nor the clinical notes could be 
retrieved or when the baseline CAARMS record could not be retrieved and the clinical notes contained 
no mentioning of mood symptom assessment. 
During study 3, the BARS criteria were incorporated into the standard psychometric assessment 
conducted at the OASIS. This required the development of a new semi-structured psychometric 
interview complementing the baseline CHR-P assessment, to specifically measure the BARS criteria. 
The Semi-structured Interview for Bipolar At Risk States (SIBARS) included a combination of several 
items adapted from well-established rating scales: (CAARMS (Yung et al., 2005); Hypomania 
Checklist-32 (Angst et al., 2005);  Altman Self-Rating Mania Scale (Altman et al., 1997); TEMPS-A 
questionnaire (Akiskal et al., 2005); QIDS-SR (Rush et al., 2003); Bergen Insomnia Scale (Pallesen et 
al., 2008); Idiopathic hypersomnia questionnaire (Vernet et al., 2010)). The SIBARS interview was 
developed for youths aged 15-35 and comprehended 5 domains: 1. Subtreshold Mania, 2. Depression, 
3. Cyclothymic Features, 4. Genetic Risk, 5. Mood Swings. Subtreshold Mania, Depression and Mood 
Swings are continuous rating scales (that include a severity and frequency anchors), while 
Cyclothyimc Features and Genetic Risk are categorical scales (yes/no). The inclusion of items for the 
SIBARS was decided by the first and last authors, with revisions made based on feedback from the 
other co-authors. The original interview is available from the authors upon request. The patients’ 
answers to the SIBARS are then rated according to pre-specified cutoffs and intake criteria that are 
detailed in Table 2. These cut-offs allow assigning the specific subgroup of the BARS criteria: 1. 
Substreshold Mania, 2. Depression+Cyclothymic Features, 3. Depression+Genetic Risk, 4. 
Cyclothymic Features+Genetic Risk, 5.Subtreshold Mixed Episode, 6. Mood Swings. A restricted 
pool of experienced clinicians (ADM, MR, MC) underwent a briefing session on the use of the 
SIBARS and then administered the interview. The scoring of the SIBARS criteria was then discussed 
under the supervision of a senior clinician (PFP) to reach consensus. 
 
2.3 Measures 
2.3.1 Demographic and baseline clinical characteristics 
For studies 1-3, demographic variables included age, gender, ethnicity, employment status, 
accommodation status, while baseline clinical characteristics included CHR-P symptom severity 
(attenuated positive psychotic symptoms as measured by the CAARMS (Yung et al., 2005)), and 
functioning (Global Assessment of Functioning GAF (Goldman et al., 1992)). Study 3 additionally 
included marital status and exposure to medications (antidepressants and mood stabilizers). 
 
2.3.2 Outcomes 
The main outcome variable was defined as the onset of a first episode of bipolar disorders, 
operationalised as in Table 2. For study 1-2 the outcome was measured through face-to-face 
interviews as well as phone contact with patients, as previously described (Falkenberg et al., 2015), 
with censoring date to August 1st 2012. For study 3 the outcomes were further assessed through the 
local electronic case register. The South London and Maudsley NHS Foundation Trust is paper-free 
and all clinical notes are recorded on the local electronic case register (Stewart et al., 2009). 
Conducting follow-up through the electronic case register allowed us to minimise the risk of dropouts. 
The use of this electronic case register for conducting follow-up studies has already been detailed and 
validated by our research group in previous publications (Fusar-Poli et al., 2016d; Fusar-Poli et al., 
2016e; Fusar-Poli et al., 2017d). Censoring date was on January 1st 2017. To minimise the biases 
associated with the use of the same scale to measure predictors (BARS+, BARS-) and outcomes 
(defined as in Table 2), in study 3 we used the ICD-10 diagnoses as gold standard against which to 
validate the SIBARS operationalization of bipolar disorders. The following ICD-10 diagnoses were 
considered: 
 
[F30.0] – Hypomania lasting more than > 4days, [F30.1] - Mania without psychotic symptoms, 
[F30.8] - Other manic episodes, [F30.9] - Manic episode, unspecified, [F31.0] - Bipolar affective 
disorder, current episode hypomanic, [F31.1] - Bipolar affective disorder, current episode manic 
without psychotic symptoms, [F31.3] - Bipolar affective disorder, current episode mild or moderate 
depression, [F31.4] - Bipolar affective disorder, current episode severe depression without psychotic 
symptoms, [F31.6] - Bipolar affective disorder, current episode mixed, [F31.7] - Bipolar affective 
disorder, currently in remission, [F31.8] - Other bipolar affective disorders (including Bipolar II 
disorder), [F31.9] - Bipolar affective disorder, unspecified, [F30.2] - Mania with psychotic symptoms, 
F31.2] - Bipolar affective disorder, current episode manic with psychotic symptoms, [F31.5] - Bipolar 
affective disorder, current episode severe depression with psychotic features. 
 
2.4. Statistical analysis  
Demographic and baseline clinical characteristics for the two cohorts (study 1-2 and study 3) were 
described using mean and SD for continuous variable, absolute and relative frequencies for categorical 
variables and median and interquartile range for ordinal variables. The association between risk groups 
and demographic and baseline clinical characteristics was assessed by one-way analysis of variance. 
Chi-square test and Fisher’s Exact Test were employed for categorical variables and Kruskal–Wallis 
test by ranks was used for ordinal variables (CAARMS severity of attenuated positive psychotic 
symptoms). 
 
For all studies (1 to 3), the clinical validity of the BAR/BARS assessment was investigated with Cox 
proportional hazards models (non-competing risk), evaluating the effects of BAR/BARS designation 
(BAR+ vs BAR- and BARS+ vs BARS-) on the development of incident bipolar disorders and time to 
development of these disorders, after checking for proportional hazards assumption (Grambsch and 
Therneau, 1994). In case of groups with zero events log-rank statistic was rather used. Incident bipolar 
disorders were defined as the emergence of bipolar disorders (see its operationalization in Table 2) 
from the aforementioned groups, at any time during the follow-up, when no similar diagnosis was 
present at baseline. We further described the cumulative incidence of the outcome of interest with 
Kaplan Meier failure function (1-survival) (Kaplan and Meier, 1958) along with the Greenwood 95% 
Cis (Greenwood, 1926). Kaplan-Meier point estimates were also reported, truncated when at least ten 
subjects were still at risk. Prognostic accuracy was investigated through discrimination measures. 
Discrimination (accurate predictions discriminate between those with and those without the outcome 
(Steyerberg et al., 2010)) was addressed with Harrell’s C-index (Royston and Altman, 2013). Values 
in the range of 0.9-1 are considered outstanding, between 0.8 and 0.9 excellent, between 0.7 and 0.8 
acceptable (Hosmer and Lemeshow, 1999). 
Since these measures do not tell us whether the BARS designation would do more good than harm if 
used in clinical practice (Vickers et al., 2016), we additionally performed net benefit analyses (for 
conceptual and methodological details see (Vickers et al., 2016)). Such an approach includes an 
“exchange rate”, a clinical judgment of the relative value of benefits (such as preventing psychosis in 
help-seeking individuals) and harms (such as unnecessary treatment) associated with the DSM-5-APS 
designation. However, as the answers to these kinds of questions and the exchange rates are 
subjective, we did not use it but rather plotted the net benefit in a decision curve analysis, as 
recommended (Vickers et al., 2016). Finally, the inter-rater reliability (IRR) of the SIBARS was 
explored in a subset of participants (n=12) with weighted kappa for ordinal variables, which is similar 
to the intra class coefficient (ICC) estimated from a two-way random effects ANOVA (Fleiss, 1973). 
All analyses were conducted in STATA 14 (STATA Corp., TX, USA). 
 
3. RESULTS 
3.1 Samples characteristics  
The initial cohort eligible for study 1 and 2 consisted of 290 CHR-P individuals. However, assessment 
reports of 85 (29.3%) patients could not be retrieved or contained insufficient information to score 
BAR criteria and were excluded from further analyses (eTable 1). The final database consisted of 205 
CHR-P individuals aged 22.58 years (SD 4.69) on average, mostly white (55.9%) males (51.71%), 
employed or student (52.97%), and living alone (59.76%), with a low functional status (GAF=59.19 
SD 10.85, eTable 1). There were no significant differences in terms of sociodemographic measures 
between the included and excluded individuals, with the exception of gender (eTable 1).  
75 individuals undergoing CHR-P assessment were included in the study 3 cohort; they were aged 
22.4 (SD 4.50) years on average and they were mostly males (72%) of white ethnicity (33.25%), 
employed or student (56.76%), single (80.56%), living in family (58.9%), never treated with 
antidepressants or mood stabilizers (57.14%) and with a low functional level (GAF=55.57, SD=8.59, 
eTable 2).  
 
3.2 Study 1: BAR criteria in the retrospective CHR-P cohort 
There were 32 (15.6%) BAR+ and 173 (84.4%) BAR- cases. There were no significant differences 
between the BAR+ and BAR- groups with respect to age, gender, ethnicity, accommodation status, 
functional status, severity of attenuated positive psychotic symptoms but BAR+ were less likely to live 
alone than the BAR- (eTable 3).  
The median follow-up period of the cohort was of 1692 days (range 362-3902). During the follow-up 
period, 13 individuals developed a bipolar disorder: 5 from the BAR+ and 8 from the BAR- group. 
The first failure was observed at 695 days and the last one at 3852 days (median 1736 days). 
Compared to the BAR- those meeting BAR+ criteria were at higher risk of developing bipolar 
disorders (HR=5.30, SE=3.11, Z=2.84, P=0.004, 95%CI 1.679 – 16.757). However, discrimination 
was poor (Harrell’s C= 0.659). The cumulative incidence of risk for psychosis for the BAR- was as 
follows: 1-year <0.001 (95%CI <0.001-<0.001), 2-year 0.007 (95%CI 0.001-0.046), 3-year 0.02 
(95%CI 0.004-0.061), 4-year  0.026 (95CI 0.001-0.08), 5-year 0.038 (95%CI 0.014-0.101), 6-year 
0.059 (0.023-0.147), 7-year 0.132 (95%CI 0.056-0.291), 8-year 0.132 (95%CI 0.056-0.291). The 
cumulative incidence of risk for psychosis for the BAR+ was as follows: 1-year <0.001 (95%CI 
<0.001-<0.001), 2-year <0.001 (95%CI <0.001-<0.001), 3-year 0.048 (95%CI 0.007-0.293), 4-year 
0.127 (95%CI 0.032-0.436), 4.4-year 0.214 (95%CI 0.07-0.543, there were too few individuals to 
report reliable point estimates beyond this time point).  
 
3.3 Study 2: BARS criteria in the retrospective CHR-P cohort 
There were 41 (20%) BARS+ and 164 (80%) BARS- cases. Individuals in the BARS+ group were 
younger, with higher functional status and less likely to live alone than those in the BARS- group 
(eTable 4). There were no other differences in demographic and baseline characteristics (eTable 4). 
The mean follow-up period of the cohort has been described above. Among the 13 transitions, 5 were 
from the BARS- and 8 from the BARS+ group. The IRR for the main BARS outcome was 0.862. 
Compared to the BARS- those meeting BARS+ criteria were at higher risk of developing bipolar 
disorders (HR=12.364, SE=7.62, Z=4.08, P<0.001, 95%CI 3.694 – 41.379). The discrimination was 
adequate (Harrell’s C= 0.777).  
The cumulative incidence of risk for psychosis for the BARS- was as follows: 1-year estimate <0.001 
(95%CI <0.001-0.001), 2,3 and 4-year estimates 0.007 (95%CI 0.001-0.049), 5,6-year estimates 0.02 
(95%CI 0.005-0.082), 7,8-year estimates 0.095 (95%CI 0.031-0.271) and for the BARS+ 1,2-year 
estimates <0.001 (95%CI <0.001-0.001), 3-year estimate 0.075 (95%CI 0.019-0.272), 4-year estimate 
0.127 (95%CI 0.042-0.350), 4.4-year estimate 0.267 (95%CI 0.115-0.546, there were too few 
individuals to report reliable point estimates beyond this timepoint).  
 
3.4 Study 3: SIBARS assessment in individuals undergoing CAARMS assessment, prospective cohort. 
The median administration time for the SIBARS assessment was 25 minutes (mean=26.31, SD=6.91). 
The assessment revealed that four individuals were already affected with a first episode of psychosis 
(FEP) at baseline. These four were then excluded from further analysis. The baseline association 
between the outcomes of the CAARMS assessment (CHR-P+, CHR-P-) and the outcomes of the 
SIBARS assessment (BARS+, BARS-, bipolar disorders) in non-psychotic cases (n=71) was non-
significant (P=0.814, Table 3). Among those CHR-P+, 22 (49%) were BARS-, 16 (36%) were 
BARS+, 7 were already affected by bipolar disorders (15%); among those CHR-P- 12 (46%) were 
BARS-, 11 (42%) BARS+ and 3 were already affected by bipolar disorders (12%) (Table 3). No 
significant group differences were found between the BARS+, BARS- and bipolar disorder groups 
regarding demographic and baseline clinical characteristics and previous exposure to antidepressants 
or mood stabilizers (eTable 5). Mean duration of follow-up was of 531 days (SD: 409.13). Over the 
course of the follow-up period, 5 individuals developed bipolar disorders, all of them in the BARS+ 
group. The conversion diagnoses were further confirmed against the ICD-10: 2 patients developed 
bipolar disorders (F31.2) or mania (F30.2) with psychotic symptoms and 3 patients developed bipolar 
II disorders (F31.81). The first transition was observed at 147 days and the last one at 1132 days, with 
a median time to transition of 539 days. The point estimates in the BARS+ group were: at 6 months 
0.048 (95%CI 0.007-0.293), at 12 months 0.098 (95%CI 0.025-0.338), at 18 months 0.167 (95%CI 
0.056-0.442), at 24 months 0.234 (95%CI 0.094-0.523). The log-rank test confirmed a significant 
between-group difference (P<0.05). The discrimination was adequate (Harrell's C = 0.742).  
The decision curve analysis showed that, compared to conducting no tests for bipolar risk (detect 
none) or considering everyone at risk (detect all), identifying individuals at risk of developing bipolar 
disorders on the basis of the BARS is associate with significant net benefits for a 0.038 to 0.23 range 
of threshold probability (individual risk of developing bipolar disorders at 3 years, Figure 3).  
 
4. DISCUSSION 
To our best knowledge this is the first study to have extended previous bipolar at-risk research 
(Bechdolf et al., 2010) in independent samples accessing CHR-P services. Our ultimate overarching 
aim was to develop a refined set of criteria to be used conjointly with a new psychometric instrument 
that could complement the current CHR-P interviews. Such an approach is in line with recent efforts 
aimed at broadening the benefits of preventative intervention to those at risk for multiple outcomes 
beyond psychosis onset (Fusar-Poli et al., 2017d). The findings of our three experiments taken 
together concur with the earlier reports indicating that it is clinically feasible to identify bipolar at-risk 
individuals within CHR-P services (Bechdolf et al., 2010). Since the CHR-P paradigm has been 
established worldwide, it may well serve as a viable platform to develop and validate bipolar at-risk 
detection and interventions. Since our aim was mainly to improve the prediction of bipolar disorders 
in CHR-P services, prognostic accuracy was selected as the key outcome across the three experiments.  
 
Our first experiment (study 1) represents the first independent validation of the original BAR criteria. 
In a large retrospective cohort representative of CHR-P samples, we found that individuals meeting 
the BAR criteria were indistinguishable from those not meeting them on several sociodemographic 
and clinical characteristics, including attenuated psychotic symptoms. The lack of baseline features 
distinguishing individuals at risk for bipolar disorders has been previously observed in these samples 
(Bechdolf et al., 2014). Similarly, the proportion of individuals meeting the BAR criteria is close to 
that observed in the original report (11% (Bechdolf et al., 2014)). We confirmed that the BAR criteria 
were associated with an increased risk of developing bipolar disorders (HR=5.30). Our study advances 
knowledge by conducting a longer follow-up compared to the 12-month previously reported (Bechdolf 
et al., 2014). We found that the between-group differences were significant only in the longer term, 
after about four years of follow-up, with the BAR+ reaching a 0.127 risk and the BAR- 0.026. 
Contrary to previous reports (Bechdolf et al., 2014), our results suggest that to detect conversions 
longer follow-up times may be required for bipolar risk compared to psychosis risk. These findings are 
of clinical relevance because external replication of BAR criteria in CHR-P samples is problematic, 
given the profound sampling biases associated with idiosyncratic recruitment strategies that are 
adopted in CHR-P services (Fusar-Poli et al., 2016e; Fusar-Poli et al., 2016g). Despite these positive 
results we also reported for the first time the prognostic accuracy of the BAR criteria, which proved to 
be poor (Harrell’s C= 0.659). This indicated the need for refining them and improving their prognostic 
accuracy. Therefore, in our second experiment (study 2) we refined the BAR intake criteria including 
new subgroups (BARS) and rechecked them in the same retrospective cohort. Individuals meeting 
BARS criteria were typically younger and with a high functional status and had an increased risk of 
developing bipolar disorders (HR=12.364) in the longer term (after 4-years). This was also confirmed 
by an improved and prognostic accuracy, which was of adequate level (Harrell’s C=0.777).  
 The next step was then to implement these criteria into a psychometric questionnaire (the SIBARS) 
and test their prognostic accuracy prospectively in our third experiment (study 3). The SIBARS 
interview was feasible in the context of a standard CHR-P assessment, taking about 25’ in addition to 
the standard CAARMS interview. We also found that about one third of CHR-P individuals (36%) 
tested positive for being at risk of bipolar disorders according to the SIBARS. This indicates that 
detection of bipolar risk stages within individuals accessing CHR-P services may be important for a 
substantial proportion of individuals. Transition risks for individuals meeting the baseline SIBARS 
criteria were already high at 18 months (0.167) and increased at 24 months (0.234). These transition 
risks are consistent to those previously observed at 12 months (Bechdolf et al., 2014). More 
importantly, the adequate prognostic accuracy of the SIBARS criteria which was observed in study 2 
was then replicated in this independent prospective sample (Harrell's C = 0.742). We further showed 
that the SIBARS criteria are associated with some potential clinical utility for a range of predicted 3-
year risk probabilities spanning from 0.038 to 0.23. Although such a range is clinically meaningful, 
longer follow-ups would be required to better estimate the upper level of this range. These initial 
results support some practical advantage associated with the use if the SIBARS in clinical research 
settings. Future research should confirm the possibility to predict outcomes other than psychosis by 
using the SIBARS interview conjointly with the CAARMS or other CHR-P psychometric tools in 
individuals accessing early detection services such as the OASIS. This would represent the first step 
towards the implementation of preventive interventions for psychosis. Effective treatments are not 
available yet but some trials in individuals at risk for bipolar disorders are underway (Pfennig et al., 
2014).  
 
There are some important limitations. First, since study 1 and 2 were based on a retrospective cohort, 
the BAR designation was assigned on the basis of information available in the clinical records, as for 
the original BAR studies (Bechdolf et al., 2010). To mitigate for major inaccuracies, we have excluded 
cases where the quality of information available was not sufficient to check the BAR criteria. Second, 
the review of case reports in studies 1 and 2 was performed by a single rater instead of having two 
independent raters perform the reviews and then reach an agreement. Third, study 3 was based on a 
relatively small sample, with a few events (transitions to bipolar disorders) only. As a consequence, 
the prognostic performance of the SIBARS should be considered as a preliminary finding in need of 
further independent validation. However, our sample size is similar to that previously used to develop 
the BAR criteria (Bechdolf et al., 2010). Similarly, our number of events (n=5) matches that reported 
by the original BAR study (n=5) (Bechdolf et al., 2010). A large prospective study recruiting 1500 
subjects to further evaluate these criteria is currently underway (www.bipolife.org) in Germany. This 
multicentre, prospective, naturalistic cohort study with a follow-up of ≥24 months per individual 
studies three risk groups: (a) Help-seeking youth and young adults aged 15–35 without a diagnosis of 
bipolar disorder but with at least one proposed risk factor (e.g. family history of bipolar disorder) 
consulting early detection centers and specialized services; (b) In-/outpatients aged 15–35 with a 
depressive episode; (c) In-/outpatients aged 15–35 with ADHD. Given that subclinical manic 
symptoms are relatively common in the general population and may fluctuate over time (Kaymaz et 
al., 2007), additional objective indicators of imminent mania such as sleep and circadian alteration 
(measured for example by sleep actigraphy (Melo et al., 2016)) or increases in activity levels (which 
may be tracked by smartphone applications (Kessing et al., 2017)) may also help to better characterize 
the bipolar risk-state.  Fourth, the psychometric properties of the SIBARS should be fully addressed 
through detailed reliability (internal consistency) and validity (construct validity, concurrent validity) 
measures beyond IRR and predictive validity, which are reported here. Fifth, our findings cannot be 
generalised to individuals at risk for bipolar disorders recruited outside individuals accessing CHR-P 
services. This means that the SIBARS is affected by the same conceptual limitations that have recently 
been observed for the CHR-P paradigm. These include substantial and idiosyncratic risk enrichment 
during the recruitment phases of individuals undergoing a CHR-P assessment (Fusar-Poli et al., 2015a; 
Fusar-Poli et al., 2016a; Fusar-Poli et al., 2016e; Fusar-Poli and Schultze-Lutter, 2016; Fusar-Poli et 
al., 2016f; Fusar-Poli et al., 2016g), clinical heterogeneity of the CHR-P subgroups(Fusar-Poli et al., 
2016a; Fusar-Poli et al., 2016b; Fusar-Poli et al., 2017a), poor penetrance of the detection strategies 
for identifying individuals at risk (Fusar-Poli et al., 2017c) and low specificity of current prognostic 
tools (Oliver et al., 2018). These problems have been detailed in specific publications by our research 
team (Fusar-Poli, 2017, 2018). Overall, these limitations indicate that additional studies are required to 
investigate the predictive validity of SIBARS criteria in the whole secondary and primary mental 
health care as well as in the general youth population (e.g. schools and colleges). 
 
5. CONCLUSIONS 
This study validates the proposed BAR criteria, refines them into BARS criteria and provides 
preliminary prognostic accuracy data for the use of a newly developed semi-structured interview 
(SIBARS) for the detection of individuals at risk of developing bipolar disorders in CHR-P services. 
Table 1 Original Bipolar At Risk criteria and refined Bipolar At Risk State criteria  
 
BAR  criteria  (Bechdolf  et  al.,  2010)     BARS  criteria  
Inclusion  criteria:  
Aged  between  15  and  25  years  and  fulfill  criteria  
of  at  least  one  of  three  groups  within  the  last  12  
months:  
  
Group  1:  Sub-­threshold  mania:  
For  at   least  2  consecutive  days  but   less   than  4  
days:   period   of   abnormally   and   persistently  
elevated,  expansive  or   irritable  mood  +  at   least  
two  criteria  from  the  list:  (1)   inflated  self-­esteem  
or  grandiosity,  (2)  decreased  need  for  sleep,  (3)  
more   talkative   than   usual   or   pressure   to   keep  
talking,   (4)   flight   of   ideas   or   subjective  
experience   that   thoughts   are   racing,   (5)  
distractibility,  (6)   increased  goal-­directed  activity  
(either   socially,   at   work,   or   sexually)   or  
psychomotor  agitation.  
  
Group  2:  Depression  +  Cyclothymic  features  
  
Depression  
For  at  least  1  week:  depressed  mood,  or  loss  of  
interest  or  pleasure  +  at  least  2  criteria  from  the  
list:   (1)   significant   weight   loss,   (2)   insomnia   or  
hypersomnia  nearly  every  day,  (3)  psychomotor  
retardation   or   agitation,   (4)   fatigue   or   loss   of  
energy,   (5)   feelings   of   worthlessness   or  
excessive   or   inappropriate   guilt,   (6)   diminished  
ability   to   think   or   concentrate,   (7)   recurrent  
thoughts  of  death,  recurrent  suicidal  ideation  
+  
Cyclothymic  features  
Numerous   episodes   with   sub-­threshold   manic  
symptoms   not   meeting   group   1   criteria   and  
numerous   episodes  with   depressive   symptoms.  
E  g.  sub-­threshold  mania  as  defined   in  group  1  
only  for  4  h  within  a  24-­hour  period  and  at  least  
4  cumulative  lifetime  days  meeting  the  criteria  
  
Group  3:  Depression  +  Genetic  risk  
Depression  
Defined  as  in  the  group  2  
+  
Genetic  Risk:  
First  degree  relative  with  bipolar  disorder    
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Inclusion  criteria:  
Aged  between  15  and  35  and  fulfill  criteria  of  at  
least   one   of   six   groups   within   the   last   12  
months:  
  
Group  1:  Sub-­threshold  mania:  
For  at   least  2  consecutive  days  but   less   than  4  
days:   period   of   abnormally   and   persistently  
elevated,  expansive  or   irritable  mood  +  at   least  
two  criteria  from  the  list:  (1)   inflated  self-­esteem  
or  grandiosity,  (2)  decreased  need  for  sleep,  (3)  
more   talkative   than   usual   or   pressure   to   keep  
talking,   (4)   flight   of   ideas   or   subjective  
experience   that   thoughts   are   racing,   (5)  
distractibility,  (6)   increased  goal-­directed  activity  
(either   socially,   at   work,   or   sexually)   or  
psychomotor  agitation.  
  
Group  2:  Depression  +  Cyclothymic  features  
  
Depression  
For  at  least  1  week:  depressed  mood,  or  loss  of  
interest  or  pleasure  +  at  least  2  criteria  from  the  
list:   (1)   significant   weight   loss,   (2)   insomnia   or  
hypersomnia  nearly  every  day,  (3)  psychomotor  
retardation   or   agitation,   (4)   fatigue   or   loss   of  
energy,   (5)   feelings   of   worthlessness   or  
excessive   or   inappropriate   guilt,   (6)   diminished  
ability   to   think   or   concentrate,   (7)   recurrent  
thoughts  of  death,  recurrent  suicidal  ideation  
+  
Cyclothymic  features  
Numerous   episodes   with   sub-­threshold   manic  
symptoms   not   meeting   group   1   criteria   and  
numerous   episodes  with   depressive   symptoms.  
E  g.  sub-­threshold  mania  as  defined   in  group  1  
only  for  4  h  within  a  24-­hour  period  and  at  least  
4  cumulative  lifetime  days  meeting  the  criteria  
  
Group  3:  Depression  +  Genetic  risk  
Depression  
Defined  as  in  the  group  2  
+  
Genetic  Risk:  
First  degree  relative  with  bipolar  disorder    
  
Group  4:  Cyclothymic  features  and  Genetic  risk  
  
Cyclothymic  features  
Numerous   episodes   with   sub-­threshold   manic  
symptoms   not   meeting   group   I   criteria   and  
numerous   episodes  with   depressive   symptoms.  
E   g.   sub-­threshold  mania   as   defined   in   group   I  
only  for  4  h  within  a  24-­hour  period  and  at  least  
4  cumulative  lifetime  days  meeting  the  criteria  
+  
Genetic  Risk:  
First  degree  relative  with  bipolar  disorder    
  
Group  5:  Sub-­threshold  mixed  Episode  
  
  
  
  
  
  
  
Exclusion  criteria:  
(a)  Past  history  of  a  treated  or  untreated  manic  
episode  of  4  days  duration  or  longer.  
(b)  Past  history  of  a  treated  or  untreated  
psychosis  of  7  days  duration  or  longer.  
(c)  Past  treatment  with  a  mood  stabilizer  for  
longer  than  6  weeks.  
(d)  Past  treatment  with  an  antipsychotic  for  3  
weeks  (equals  15  mg  per  week  of  haloperidol  or  
equivalent).  
(e)  Evidence  from  medical  records  for  an  IQ  
below  the  normal  range.  
(f)  Organic  brain  disorder.  
  
  
Conversion  criteria:  
Hypomania/mania  related  additions  or  
alterations  to  existing  treatments,  or  initiation  of  
new  treatment  (psychopharmacological  
medication,  admission)  by  the  treating  physician  
Sub-­threshold   mania   AND   depressed   mood  
nearly   every   day   but   less   than   5   consecutive  
days  
  
Group  6:  Mood  swings  
Recent  onset  mood  instability    
  
Exclusion  criteria:  
(a)  Past  history  of  a  treated  or  untreated  
CAARMS-­defined  psychosis  of  7  days  duration  
or  longer.  
(b)  Past  treatment  with  a  mood  stabilizer  for  
longer  than  6  weeks.  
(c)  Past  treatment  with  an  antipsychotic  for  3  
weeks.  
(d)  Evidence  from  medical  records  for  an  IQ  
below  the  normal  range.  
(e)  Organic  brain  disorder.  
(f)   Past   history   of   bipolar   disorders   (including  
bipolar-­II-­disorder   and   hypomania   lasting   more  
than  4  days)  
  
Transition  criteria:  
Development  of  any  bipolar  disorder  –defined  in  
table  2-­    
 
Table 2. Intake criteria of the Semistructured Interview for Bipolar At Risk States, SIBARS. 
Age  15-­35,  not  meeting  any  of  the  exclusion  criteria  and  meeting  at  least  one  of  the  following:  
GROUP  1:  SUB  THRESHOLD  MANIA                                                                                                                                            
Subthreshold  intensity  of  the  Subtreshold  Mania  scale  (SIBARS  1):  
Severity  score  of  3  –  4  PLUS  Frequency  score  of  3  –  6  
Subthreshold  frequency  of  the  Subtreshold  Mania  scale  (SIBARS  1):    
Severity  score  of  5  -­  6  PLUS  Frequency  score  of  ≤  3  
PLUS  
Symptoms  should  not  have  been  present  for  more  than  4  days  
Group  2:  DEPRESSION+CYCLOTHYMIC  FEATURES    
Depression:  
Subthreshold  intensity  of  the  Depression  scale  (SIBARS  2):  
Severity  score  of  3  –  5  PLUS  Frequency  score  of  3  –  6  
Subthreshold  frequency  of  the  Depression  scale  (SIBARS  2):    
Severity  score  of  6  PLUS  Frequency  score  of  ≤  3  
Cyclothymic  features:    
Total  score  on  the  Cyclothymic  Features  rating  (SIBARS  3):  
Score  ≥  11  
Group  3:  DEPRESSION+GENETIC  RISK                                                                                                                                
Genetic  Risk:    
First  degree  relative  with  bipolar  disorder  (SIBARS  4)  
PLUS    
Depression:  
Subthreshold  intensity  of  the  Depression  scale  (SIBARS  2):  
Severity  score  of  3  –  5  PLUS  Frequency  score  of  3  –  6  
Subthreshold  frequency  of  the  Depression  scale  (SIBARS  2):    
Severity  score  of  6  PLUS  Frequency  score  of  ≤  3  
Group  4:  CYCLOTHYMIC  FEATURES  +  GENETIC  RISK  
Genetic  Risk:    
First  degree  relative  with  bipolar  disorder  (SIBARS  4)  
PLUS  
Cyclothymic  features:    
Total  score  on  the  Cyclothymic  Features  rating  (SIBARS  3):  
Score  ≥  11  
Group  5  :  SUBTHRESHOLD  MIXED  EPISODE:  
Subtreshold  mania:  
Subthreshold  intensity  of  the  Subtreshold  Mania  scale  (SIBARS  1):  
Severity  score  of  3  –  4  PLUS  Frequency  score  of  3  –  6  
Subthreshold  frequency  of  the  Subtreshold  Mania  scale  (SIBARS  1):    
Severity  score  of  5  -­  6  PLUS  Frequency  score  of  ≤  3  
PLUS  
Depression:  
Subthreshold  intensity  of  the  depression  scale  (SIBARS  2):  
Severity  score  of  3  –  5  PLUS  Frequency  score  of  3  –  6  
Subthreshold  frequency  of  the  depression  scale  (SIBARS  2):    
Severity  score  of  6  PLUS  Frequency  score  of  ≤  3  
PLUS  
Symptoms  should  not  have  been  present  for  more  than  4  days  
Group  6:  MOOD  SWINGS:                                                                                                                                                                                        
Severity  score  of  3  –  6  of  the  mood  swings  scale  (SIBARS  5)  
PLUS  
Frequency  score  of  3  –  6  of  the  mood  swings  scale  (SIBARS  5)    
Bipolar  I  THRESHOLD  
Severity  score  of  5  or  6  on  the  Subtreshold  Mania  scale  (SIBARS  1)  
PLUS  
Frequency  score  of  greater  than  or  equal  to  4  on  the  Subtreshold  Mania  (SIBARS  1)  
PLUS  
Symptoms  present  for  more  than  4  days  
Bipolar  II  THRESHOLD  
Severity  score  of  the  Depression  scale  (SIBARS  2)  less  than  6  
PLUS  
Severity  and  frequency  scores  of  the  Subthreshold  Mania  scale  (SIBARS  2)  of  4    
PLUS  
Symptoms  present  for  more  than  4  days  
Figure 1. Kaplan-Meier failure estimates for the SIBARS interview in individuals accessing CHR-P 
services (n=71). There were 18 individuals at risk at 6 months, 17 at 12 months, and 11 at 24 months 
in the BARS- group and 21 individuals at risk at 6 months, 19 at 12 months, and 12 at 24 months in 
the BARS+ group. Estimates beyond this timepoint are plotted but should be considered cautiously.  
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Table	  3.	  Association	  between	  the	  CAARMS	  and	  SIBARS	  baseline	  assessments	  
(n=71).	  
	   	  
CHR-­‐P+	   CHR-­‐P-­‐	   Total	  
BARS-­‐	   n	   22	   12	   34	  
	  
frequency	   21.5	   12.5	   34	  
	  
column	  percentage	   48.89	   46.16	   47.89	  
BARS+	   n	   16	   11	   27	  
	  
frequency	   17.1	   9.9	   27	  
	  	   column	  percentage	   35.56	   42.31	   38.03	  
Bipolar	  Disorders	   n	   7	   3	   10	  
	  
frequency	   6.3	   3.7	   10	  
	  
column	  percentage	   15.56	   11.54	   14.8	  
Total	   n	   45	   26	   71	  
	  
frequency	   45	   26	   71	  
	  
column	  percentage	   100	   100	   100	  
X2=0.421,	  P=0.814	  
Figure 2. Decision Curve Analysis indicating the clinical utility (net benefits) associated with the use 
of the SIBARS for the detection of individuals at risk of developing bipolar disorders amongst those 
accessing CHR-P services.  
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